SSP
PFE icon

Sapphire Star Partners’s Pfizer PFE Stock Holding History

Sapphire Star Partners’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-9,486
Closed -$317K – 81
2016
Q2 		$317K Sell
9,486
-9,486
-50% -$303K 0.41% 36
2016
Q1 		$580K Buy
18,972
+9,486
+100% +$271K 0.46% 33
2015
Q4 		$290K Buy
+9,486
New +$298K 0.38% 40

Other funds holding PFE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Sapphire Star Partners's PFE Position: Q3 2016 in Review

Sapphire Star Partners sold out of Pfizer (PFE) in Q3 2016, closing a stake of 9,486 shares — an estimated $317K sold.

Sapphire Star Partners first reported a position in PFE in Q4 2015 and held it in 3 quarters. The position peaked at $580K in Q1 2016. 1,962 funds tracked by Wall St. Rank hold PFE as of Q3 2016.

  • Sapphire Star Partners reported no remaining Pfizer position as of Q3 2016 after selling out during the quarter.
  • Sapphire Star Partners sold 9,486 Pfizer shares in Q3 2016, an estimated $317K.
  • Sapphire Star Partners first reported a position in Pfizer in Q4 2015 and held it in 3 quarters.
  • Sapphire Star Partners's Pfizer position peaked at $580K in Q1 2016.
  • 1,962 funds tracked by Wall St. Rank held Pfizer as of Q3 2016.

Based on Sapphire Star Partners's 13F filing for Q3 2016, filed 14 Nov 2016.